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Mcl-1 full-length (Mcl-11–350), a tightly regulated protein, plays an important role in protecting cells
against apoptosis. Cleavage of Mcl-1 at Asp127 by caspase (Mcl-1C1) contributes to the regulation of
Mcl-1 expression, but its pro-apoptotic function remains controversial. Here, we reported that Mcl-
1128–350 expression induced caspase-dependent apoptosis. We demonstrated that Mcl-1128–350 but
not Mcl-11–350 interacts with Bax. This interaction required an intact BH3 Mcl-1128–350 domain and
leads to Bax activation and translocation to mitochondria. The silencing of Bax, but not of Bak, pre-
vented Mcl-1128–350 induced apoptosis. In conclusion, Mcl-1128–350 exerts a pro-apoptotic function
governed by its capacity to interact with Bax.
Structured summary:
MINT-7306752: Mcl-1 (uniprotkb:Q07820) physically interacts (MI:0915) with BAK (uniprotkb:Q16611)
by anti tag coimmunoprecipitation (MI:0007)
MINT-7306728: Mcl-1 (uniprotkb:Q07820) physically interacts (MI:0914) with BAX (uniprotkb:Q07812)
and BAK (uniprotkb:Q16611) by anti tag coimmunoprecipitation (MI:0007)
MINT-7307171: F1 ATPase (uniprotkb:Q5TC12), Mcl-1 (uniprotkb:Q07820) and BAX (uniprotkb:Q07812)
colocalize (MI:0403) by cosedimentation through density gradients (MI:0029)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mcl-11–350 was ﬁrst discovered as a gene induced during differ-
entiation of the myeloid leukemia cell line, ML-1 [1]. Mcl-11–350,
similar to Bcl-2, acts as an anti-apoptotic protein to prevent
mitochondria dysfunction by sequestering pro-apoptotic family
members. Mcl-11–350 has been shown to directly interact with
BH3-only proteins Bim and t-Bid and thereby inhibits their pro-
apoptotic activity [2,3]. Mcl-11–350 possesses Bcl-2 homology
(BH) domains 1–3 and a NH2-terminus much longer than otherchemical Societies. Published by E
gle medium; HEPES, 4-(2-
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t).pro-survival BCL-2 members. It also contains two proline-, glu-
tamic acid-, serine-, and threonine rich sequences that have been
thought to be responsible for its rapid degradation. Indeed, Mcl-1
is unique among anti-apoptotic members of the BCL-2 family in
that it is a very short-lived molecule [4]. Both, proteasomal and
caspase-mediated cleavages of Mcl-11–350 contribute to Mcl-1
down-regulation in response to signals that trigger cell death [5].
Mcl-1 cleavage was ﬁrst observed during Fas-mediated apoptosis
in Jurkat T cells [6] then associated with chemotherapy-induced
apoptosis in diverse cancer cells [7–9]. Mcl-11–350 can be cleaved
at two different sites (Asp 127 and Asp 157) by caspases, speciﬁ-
cally caspase-3, but it is thought, that the Mcl-1128–350 (Asp 127)
cleavage product is the predominant form in apoptotic cells [10].
Although Mcl-1 is not the only anti-apoptotic molecule cleaved
by caspases, it appears as a more efﬁcient caspase target than
Bcl-2 or Bcl-xL [10]. These cleaved fragments of Mcl-1 resemble
to Bax-like proteins containing BH1, BH2 and BH3 domains and
an intact C-terminal domain. The exact role of these Mcl-1 cleavage
products remains controversial. Some studies have shown thatlsevier B.V. All rights reserved.
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[10,11], while others have shown that these fragments alone did
not exert any apoptotic effect [12,6]. This controversy prompted
us to examine the functional role of these fragments in different
cellular contexts.
2. Materials and methods
2.1. Cell culture and transfection
The human embryonic kidney cell line HEK-293 was cultured in
Dulbecco’s modiﬁed Eagle medium supplemented with 10% FCS.
Myeloma (KMM1, gift from Dr. Otsuki, Kurashiki, Japan) and mel-
anoma (M88, gift from Dr. F. Jotereau, Nantes, France) cell lines
were cultured in RPMI 1640 with 5% and 10% FCS, respectively.
Cells were transfected with 5 lg pcDNA3 plasmid or 100 pmol
small interfering RNA (siRNA) (scramble, Bax or Bak siRNA, Dharm-
acon) using Lipofectamine™ 2000 (Invitrogen) according to manu-
facturer’s instructions.
2.2. Reagents and antibodies
Antibodies used were anti-actin (Transduction Laboratory),
anti-Bax (Immunotech), anti-Bak (Calbiochem), anti-Bcl-2 (Dako),
anti-Bcl-xL (Cell signaling), anti-myc (Invitrogen), anti-caspase-3
(Santa Cruz Technology), anti-tubulin (Amersham) and anti-
F1ATPase (Molecular Probes). Caspase inhibitors benzoyloxycar-
bonyl-VAD-ﬂuoromethyl ketone and benzoyloxycarbonyl-LEHD-
ﬂuoromethyl ketone were from Promega and Calbiochem,
respectively.
2.3. Mcl-1 constructs and plasmids
Myc-tagged pcDNA3 containing full-length Mcl-1 (Mcl-11–350)
and Mcl-1128–350 were kindly provided by J. Reed and G. Packham,
respectively. Plasmid encoding Mcl-1128–350 was subjected to site
directed mutagenesis to generate L213A and D218A mutants
(Mcl-1128–350mtBH3) using the following primers 50ACGCCAGCCCC-
AACCCGTCGAGCGGTCTCCAGCGCCTT30 and 50GCAGCGCAACCACG-
AGACGGCCTTCCAAGGCAT30. Plasmid encoding non-cleavable full
length Mcl-1 (Mcl-11–350dm) was obtained by replacing conserved
residues D127 and D157 by Ala (GENECUST).
2.4. Assay for detection of apoptotic cells and Bax and Bak activation
Cell death was assessed by Apo 2.7 (Beckman Coulter) staining.
For Bax and Bak activation, cells were ﬁxed using Intra Prep Perme-
abilization Reagent Kit (Immunotech). Then, cells were incubated
with anti-Bax (clone 6A7, R&D), anti-Bak (rabbit polyclonal, BD
Pharmingen) or their respective isotype control for 20 min. After
washed in PBS, cells were incubated with anti-mouse-FITC or
anti-rabbit-FITC antibodies for 20 min, washed in PBS and
resuspended in PBS 1% formaldehyde. Flow cytometry analysis
was performed on a FACSCalibur using the Cell Quest software.
2.5. Subcellular fractionation
Cells were washed once with ice-cold PBS, incubated in hypo-
tonic buffer (5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfon-
ic acid pH 7.4, 25 mM sucrose, 2 mM EDTA, 2 lM aprotinin,
0.4 mM Pefabloc) for 30 min on ice. Cells were disrupted with a
dounce homogeniser and 2 M sucrose was added to reach
250 mM sucrose ﬁnal concentration. Then, lysates were centri-
fuged at 500g at 4 C for 10 min to eliminate the nuclear pellet
and unbroken cells. The collected supernatant was centrifuged at10 000g at 4 C for 15 min to obtain the heavy membrane pellet.
The supernatant was kept as the cytoplasmic fraction. Heavy mem-
brane pellet was resuspended in lysis buffer.
2.6. Immunoprecipitation and immunoblotting
Immunoprecipitation and Western blotting analysis were per-
formed as previously described [13].
2.7. Statistical analysis
Statistical analysis was performed using Wilcoxon test.3. Results
3.1. Mcl-1128–350 induces apoptosis through Bax activation
Since the pro-apoptotic function of cleaved form of Mcl-1 (Mcl-
1128–350) remained contested,we assessed its function in several cell
lines, HEK-293, KMM1 and M88 cells. To this purpose, cells were
transiently transfected with Mcl-1 plasmids containing either full
length Mcl-1 (Mcl-11–350) or the fragment Mcl-1128–350 and then
apoptosis was determined by Apo2.7 staining. To verify the expres-
sion of the different constructs, Western blotting analysis was
carried out using anti-myc antibody. As shown in Fig. 1A, both
Mcl-11–350 and Mcl-1128–350 were efﬁciently expressed in all cell
lines. As expected, Mcl-11–350 did not induce apoptosis, whereas a
signiﬁcant number of Apo2.7 positive cells were present in
Mcl-1128–350 transfected HEK-293 (49%), KMM1 (51%) and M88
(26%) cells (Fig. 1B). To characterizeMcl-1128–350 induced-apoptosis,
we investigated caspase-3 processing and Bax activation. Bax con-
formational change was assessed by ﬂow cytometry analysis using
an antibody speciﬁc for the active form of Bax. We found that
Mcl-1128–350 induced the activation of caspase-3 and Bax in
HEK-293, KMM1 and M88 cells (Fig. 1A and C). Furthermore,
addition of pan-caspase inhibitor z-VAD-fmk totally abolished
Mcl-1128–350 induced-apoptosis (91% inhibition) (Fig. 1D). Speciﬁc
inhibitionof caspase-9by z-LEHD-fmk stronglyprevented cell death
(72% inhibition) indicating the involvement of the mitochondrial
pathway (Fig. 1D).
3.2. Intact BH3 domain of Mcl-1128–350 is required for physical
interaction between Mcl-1128–350 and Bax
Since we observed a signiﬁcant Bax activation in the presence of
Mcl-1128–350, we looked for a potential interaction between these
proteins. We found that Mcl-11–350 was not associated with Bax, as
already reported [14,15],whereas a strongBax/Mcl-1128–350 interac-
tionwasdetected (Fig. 2A).Ofnote, bothMcl-1128–350 andMcl-11–350
interacted with Bak (Fig. 2A). However, Mcl-1128–350 did not induce
Bak activation analyzed by ﬂow cytometry (data not shown).
Furthermore, Fig. 2A shows that Mcl-1128–350 is not able to interact
neither with Bcl-2 nor Bcl-xL suggesting the speciﬁcity of the inter-
action of Mcl-1128–350 with Bax. To further investigate the domain
involved in the interaction between Mcl-1128–350 and Bax, we
generated a double mutant of the BH3 domain of Mcl-1128–350
(Mcl-1128–350mtBH3). Fig. 2A shows that Mcl-1128–350mtBH3 can no
longer interact with Bax and Bak. Cell fractionation showed that
Mcl-1128–350 was mainly localized in the mitochondrial compart-
ment whereas Mcl-1128–350mtBH3 was equally distributed in both
the cytosolic and mitochondrial compartments. Interestingly,
Mcl-1128–350 induced the translocation of Bax to mitochondria
whereas Mcl-1128–350mtBH3 did not longer have this property
(Fig. 2B). Moreover, Mcl-1128–350mtBH3 had no more pro-apoptotic
effect as shown by the absence of both positive Apo2.7 cells and
Fig. 1. Mcl-1128–350 induced apoptosis in epithelial kidney (HEK), myeloma (KMM1) and melanoma (M88) cells through Bax activation. HEK-293, KMM1 and M88 were
transiently transfected with empty pcDNA3.1 or pcDNA3.1 containing either Mcl-11–350 or Mcl-1128–350. (A) 48-h post transfection, cells were collected and protein expression
was analyzed by Western blotting analysis. Membrane was probed with the indicated antibodies. (B) 48 h post transfection, cells were quantiﬁed for cell death using Apo 2.7
staining or (C) for Bax activation using the conformation dependent antibody (6A7). Results are representative of three independent experiments. (D) HEK-293 cells were
transfected with myc-tagged Mcl-1128–350 and cultured in the presence of 50 lM z-VAD-fmk or z-LEHD-fmk for 48 h and then were analyzed using Apo2.7-PE staining.
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evidence that an intact BH3 domain is required for Bax/Mcl-1128–350
interaction, Bax activation and apoptosis.
3.3. Bax knockdown inhibits Mcl-1128–350 induced apoptosis
To further demonstrate whether the pro-apoptotic function of
Mcl-1128–350 was dependent on Bax, we used siRNA technology
for Bax knockdown. As shown in Fig. 3, knockdown of Bax (78% de-
crease) correlated with a strong reduction in both cell death (53%
decrease) and caspase-3 processing induced by Mcl-1128–350
(Fig. 3A and B). Thus, this result showed that Bax was required
for Mcl-1128–350 induced apoptosis. Finally, we demonstrated that
Bak and Bax do not exert redundant functions in Mcl-1128–350 in-
duced apoptosis. Indeed, a Bak knockdown (69% decrease) had a
very weak effect on both cell death (10% decrease) and caspase-3
processing induced by Mcl-1128–350 (Fig. 3A and C).
3.4. Non-cleavable Mcl-1mutant (Mcl-11–350dm) induced a better
protection to apoptosis than Mcl-11–350
We have shown in a previous study that freed Bim from Mcl-1/
Bim endogenous complexes and the cleavage of Mcl-1 were both
associated with melphalan-induced apoptosis [7]. According to
the fact that Mcl-1128–350 has a pro-apoptotic function, we hypoth-
esized that over expression of the non-cleavable Mcl-1 mutant
(Mcl-11–350dm) should render myeloma cells more resistant to mel-
phalan induced-apoptosis than Mcl-11–350 over expression. To ad-
dress this hypothesis, we evaluated cell apoptosis after transient
over expression of either Mcl-11–350dm or Mcl-11–350 in KMM1myeloma cells (Fig. 4A). We showed that Mcl-11–350dm protects
cells from melphalan induced-apoptosis more efﬁciently than
Mcl-11–350 (45% of inhibition vs. 25%, P = 0.007) (Fig. 4B). To deter-
mine if Bim release interfere with the differences of apoptosis ob-
served above, we performed the same experiment in the presence
of siRNA Bim (Fig. 4C). We showed that Bim silencing itself reduced
apoptosis induced by melphalan. Of interest, despite Bim silencing,
Mcl-11–350dm protected cells more efﬁciently than Mcl-11–350. Alto-
gether these results show that Mcl-1C1 and Bim released concurred
to melphalan induced-apoptosis.4. Discussion
In the present study, we demonstrated that Mcl-1128–350 in-
duced apoptosis through Bax activation in human cell lines of dif-
ferent origin (embryonic kidney, myeloma and melanoma cells),
indicating that its pro-apoptotic function does not appear to be
dependent on cell types. These results were in agreement with
the study by Weng et al., showing that the cleaved form of Mcl-1
at Asp 157 (Mcl-1C2) induced a caspase dependent apoptosis in
HeLa cells [11]. However, our results disagree with other studies
[12,6]; the discrepancy between the disparate ﬁndings could be
due to the different factors such as cellular model, transfection
method, cell death detection at different times making difﬁcult
to draw a deﬁnitive conclusion. The inhibition of cell death by a
caspase-9 inhibitor demonstrates that Mcl-1128–350 induced apop-
tosis via the mitochondrial pathway. Cleavage of anti-apoptotic
members of Bcl-2 family by caspases seems a common feature of
these proteins since cleaved forms of Bcl-2 and Bcl-xL have been
Fig. 2. The BH3 domain of Mcl-1128–350 is required for Bax interaction, translocation to mitochondria and induction of cell death. HEK-293 cells were transiently transfected
with myc-tagged Mcl-11–350, Mcl-1128–350 or Mcl-1128–350mtBH3 cDNAs. (A) 48 h later immunoprecipitations with 5 lg anti-myc antibody were performed and the presence of
immunocomplexes was determined by Western blotting analysis. (B) Transfected cells were subjected to cellular fractionation. Fractions (C: cytosolic, M: mitochondrial)
were separated in SDS–PAGE and membrane probed with the indicated antibodies. F1ATPase and tubulin were included as mitochondrial and cytosolic controls, respectively.
(C) Cells were analyzed for Apo 2.7 staining and (D) cell lysates for caspase-3 activation by Western blotting.
Fig. 3. Apoptosis triggered by Mcl-1128–350 occurs through a Bax dependent mechanism. HEK-293 cells were co-transfected with myc-tagged Mcl-1128–350 cDNA in the
presence of control, Bax or Bak siRNA. (A) 48 h post transfection, cells were analyzed for Apo2.7 staining. (B) Cell lysates were subjected to Western blotting and membrane
was probed with respective antibodies.
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Fig. 4. Mcl-11–350dm is more efﬁcient than Mcl-11–350 to protect cells against apoptosis. KMM1 cells were transfected with empty pcDNA-3, myc-tagged Mcl-11–350 cDNA or
myc-tagged Mcl-11–350dm cDNA. (A) 48 h post transfection, Mcl-11–350 and Mcl-11–350dm protein expression was analyzed by Western blotting analysis. (B) Cell death was
analyzed using Apo2.7 staining. (C) KMM1 cells were co-transfected with empty pcDNA-3, myc-tagged Mcl-11–350 cDNA or myc-tagged Mcl-11–350dm cDNA in the presence of
control or Bim siRNA. 24 h post transfection, 5 lM melphalan was added for 48 h and cells were analyzed for Apo2.7 staining.
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pro-apoptotic function of Bcl-2 and Bcl-xL cleaved forms has been
proposed. In a previous study, we have shown that melphalan
induced-apoptosis was associated with both Bim release and
Mcl-1 cleavage. Interestingly, a non-cleavable Mcl-1 mutant
(Mcl-11–350dm) induces better protection against melphalan
induced-apoptosis than Mcl-11–350 supporting the role of Mcl-1
cleavage in apoptosis induction. Furthermore, whereas the silenc-
ing of Bim by siRNA decreases melphalan induced-apoptosis it
does not interfere with the gain of apoptosis protection due to
Mcl-11–350dm. Altogether, these results indicates that Mcl-1 cleaved
form is implicated in melphalan induced-apoptosis directly, even
though both Mcl-1 cleaved form and Bim contribute to melphalan
induced-apoptosis.
We demonstrated that Mcl-1128–350 strongly interacted with
Bax and that this interaction is dependent on the intact BH3 do-
main of Mcl-1128–350. Then, we further provide evidence that the
BH3 domain is also required for Bax activation and apoptosis. This
result was consistent with previous reports showing that a physi-
cal interaction between Bax and the BH3 domain of either Bid or
Puma was necessary to induce Bax dependent apoptosis [18].
Apoptosis induced by Nbk/Bik was also shown to occur through a
Bax-dependent mechanism [19]. Collectively, our data support a
model in which Mcl-1128–350 exerts a pro-apoptotic function in
very different cell types governed by its capacity to interact phys-
ically with Bax. Mcl-1 cleavage appears to be associated with very
different pro-apoptotic stimuli (chemotherapy [7–9], inhibition of
proteasome [20], death receptor signaling [21] and cytokine depri-
vation [22]) and occurs very early, suggesting a role of Mcl-1128–350
as both an inducer and an ampliﬁer of apoptosis. Based on this
study, we can propose that this cleaved fragment has an active role
in mitochondrial perturbation via direct activation of Bax.
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